This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Reitz A et al. (2004) European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 45: 510–515
Kuo HC (2004) Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents. Urology 63: 868–872
Zuber M et al. (1993) Botulinum antibodies in dystonic patients treated with type A botulinum toxin: frequency and significance. Neurology 43: 1715–1718
Kessler KR et al. (1999) Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group. J Neurol 246: 265–274
Reitz A and Schurch B (2004) Botulinum toxin type B injection for management of type A resistant neurogenic detrusor overactivity. J Urol 171: 804–805
Acknowledgements
The synopsis was written by Sandra Michelmore, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Kuo, HC. Do repeat injections of botulinum toxin type A for detrusor overactivity lead to resistance?. Nat Rev Urol 2, 414–415 (2005). https://doi.org/10.1038/ncpuro0273
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpuro0273